APA (7th ed.) Citation

PE, P., J, K., T, B., H, B., R, C., K, P., . . . J, B. (2026). Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: An analysis from the UK Severe Asthma Registry. ERJ open research, 12(1), . https://doi.org/10.1183/23120541.00565-2025

Chicago Style (17th ed.) Citation

PE, Pfeffer, et al. "Real-world Effectiveness of Biologic Therapies in Severe Asthma Patients Ineligible for Phase 3 Randomised Controlled Trials of Biologics: An Analysis from the UK Severe Asthma Registry." ERJ Open Research 12, no. 1 (2026). https://doi.org/10.1183/23120541.00565-2025.

MLA (9th ed.) Citation

PE, Pfeffer, et al. "Real-world Effectiveness of Biologic Therapies in Severe Asthma Patients Ineligible for Phase 3 Randomised Controlled Trials of Biologics: An Analysis from the UK Severe Asthma Registry." ERJ Open Research, vol. 12, no. 1, 2026, https://doi.org/10.1183/23120541.00565-2025.